Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial

Published:2003-10-27 Issue:7 Volume:92 Page:741-747
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Homma Y.,Paick J.S.,Lee J.G.,Kawabe K.,

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410X.2003.04468.x/fullpdf

Reference23 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society;Abrams;Neurourol Urodyn,2002

2. The mechanism of action of tolterodine;Nilvebrant;Rev Contemp Pharmacother,2000

3. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder;Abrams;Br J Urol,1998

4. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder;Drutz;Int Urogynecol J Pelvic Floor Dysfunct,1999

5. Tolterodine: superior tolerability and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial;Malone-Lee;J Urol,2001

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia;Expert Opinion on Drug Safety;2023-12-02

2. Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis;International braz j urol;2023-10

3. A Retrospective Database Analysis to Investigate Treatment Patterns and Health Care Resource Utilisation in Patients who CYCLe AntiMuscarinics in ENgland (CYCLAMEN);European Urology Focus;2023-10

4. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults;Cochrane Database of Systematic Reviews;2023-05-09

5. Comparative Assessment of Efficacy and Safety of approved Oral Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis;2023-02-07